Recent searches
Search options
Administered by:
Novavax's protein-based COVID vaccine induces broadly neutralizing responses against XBB subvariants, including EG.5.1 and XBB.1.16.6.
#vaccine #Novavax
https://www.prnewswire.com/news-releases/novavaxs-updated-protein-based-xbb-covid-vaccine-induced-neutralizing-responses-against-emerging-subvariants-including-eg5-1-and-xbb1-16-6--301906172.html
www.prnewswire.comNovavax's Updated Protein-based XBB COVID Vaccine Induced Neutralizing Responses Against Emerging Subvariants, Including EG.5.1 and XBB.1.16.6/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its...